Trials / Withdrawn
WithdrawnNCT00718055
Magnetic Resonance Imaging (MRI) Using Liverspecific Oral Contrast Agent in Metastatic Colorectal Cancer Patients
MR Skanning Med Leverspecifikt Oralt Kontraststof Sammenlignet Med CT Skanning Hos Colorectalcancer Patienter Med Levermetastaser
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Copenhagen University Hospital at Herlev · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether MRI with manganese containing contrast agent detects more livermetastasis compared to CT scan
Conditions
Timeline
- Start date
- 2006-11-01
- First posted
- 2008-07-18
- Last updated
- 2009-02-10
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT00718055. Inclusion in this directory is not an endorsement.